FLT1 and non-small cell lung carcinoma: This association was also observed in advanced or recurrent NSCLC patients treated with bevacizumab and chemotherapy who were carriers of the FLT1 rs9554316(T) allele [30], which is correlated with the rs7993418(C) allele (D’ = 1.0, r2 = 0.98).